Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset - HMS LINCS Database

Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20343)

Filter results: >>>>

Cell	Small Molecule	Small Mol Concentration (uM)	Primary Target	Pathway	Mean Normalized Growth Rate Inhibition Value	Increased Fraction Dead
MCF 10A	Cediranib	0.01	VEGFR/cKIT	RTK	1.0016	-0.00009
MCF 10A	Cediranib	0.1	VEGFR/cKIT	RTK	1.0093	-0.00083
Hs 578T	Cediranib	3.1623	VEGFR/cKIT	RTK	0.1560	0.19759
MCF 10A	Cediranib	0.0031623	VEGFR/cKIT	RTK	1.0035	-0.00027
MCF 10A	Cediranib	0.031623	VEGFR/cKIT	RTK	1.0136	0.00006
Hs 578T	Cediranib	0.031623	VEGFR/cKIT	RTK	0.8397	0.01896
Hs 578T	Cediranib	0.001	VEGFR/cKIT	RTK	1.0163	-0.00048
Hs 578T	Cediranib	1.0	VEGFR/cKIT	RTK	0.3858	0.10669
Hs 578T	Cediranib	10.0	VEGFR/cKIT	RTK	-0.5723	0.81093
MCF 10A	Cediranib	0.001	VEGFR/cKIT	RTK	1.0032	0.00120
Hs 578T	Cediranib	0.1	VEGFR/cKIT	RTK	0.7275	0.02636
HCC1806	Cediranib	0.031623	VEGFR/cKIT	RTK	0.9721	0.00716
Hs 578T	Cediranib	0.0031623	VEGFR/cKIT	RTK	0.9935	0.00404
Hs 578T	Cediranib	0.01	VEGFR/cKIT	RTK	0.9644	0.00188
HCC1806	Cediranib	0.0031623	VEGFR/cKIT	RTK	1.0810	-0.01058
HCC1806	Cediranib	1.0	VEGFR/cKIT	RTK	1.0383	0.00958
HCC1806	Cediranib	0.31623	VEGFR/cKIT	RTK	0.9459	0.01658
Hs 578T	Cediranib	0.31623	VEGFR/cKIT	RTK	0.5611	0.05612
HCC1806	Cediranib	3.1623	VEGFR/cKIT	RTK	0.8954	0.02498
HCC1806	Cediranib	0.001	VEGFR/cKIT	RTK	0.9923	0.00046
HCC1806	Cediranib	10.0	VEGFR/cKIT	RTK	0.0954	0.27518
HCC1806	Cediranib	0.1	VEGFR/cKIT	RTK	0.9983	0.00263
HCC1806	Cediranib	0.01	VEGFR/cKIT	RTK	1.0401	0.00080
MCF 10A	Cediranib	1.0	VEGFR/cKIT	RTK	1.0068	0.00027
MCF 10A	Cediranib	0.31623	VEGFR/cKIT	RTK	1.0087	-0.00055